• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较接受放疗的低分化与间变性甲状腺癌的治疗结果:一项监测、流行病学和最终结果分析。

Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.

作者信息

Arora Shruthi, Christos Paul, Pham Anthony, Desai Prashant, Wernicke A Gabriella, Nori Dattatreyudu, Chao K S C, Parashar Bhupesh

机构信息

Department of Radiation Oncology, Stich Radiation Center, New York, NY 10065, USA.

出版信息

J Cancer Res Ther. 2014 Jul-Sep;10(3):526-30. doi: 10.4103/0973-1482.138207.

DOI:10.4103/0973-1482.138207
PMID:25313732
Abstract

PURPOSE

Poorly differentiated thyroid carcinoma (PDTC) and anaplastic thyroid carcinoma (ATC) are considered the most aggressive cancers of the head and neck. The aim of the study was to evaluate and compare survival outcomes in PDTC and ATC in a large population-based cohort.

MATERIALS AND METHODS

Patients with PDTC and ATC diagnosed from 1973 to 2008 were obtained from Surveillance, Epidemiology, and End RESULTS database. Kaplan-Meier survival analysis and log-rank analyses were performed to evaluate (1) The effect of histology on cause-specific survival (CSS) and (2) the influence of factors such as treatment, treatment sequence, race, sex, and age on CSS. Multivariate analysis was performed to assess the independent effect of these factors on CSS.

RESULTS

A total of 1352 patients with PDTC and ATC were identified. PDTC constituted 52.4% of patients versus 47.6% for ATC. Median CSS was similar in the two histology groups (P = 0.14). Both PDTC and ATC patients receiving radioisotopes showed a significantly better CSS compared to external beam radiation (P < 0.0001). PDTC and ATC Patients receiving radiation prior to surgery demonstrated a significantly lower CSS compared to patients receiving radiation postoperatively (P < 0.0001). Female gender and black/nonwhite race tended to improve CSS in PDTC and ATC patients (P = 0.29 and P = 0.03, for gender and race, respectively). However, multivariate analysis revealed only type of radiation treatment and age to be independently associated with CSS.

CONCLUSION

This is the first large population-based study evaluating PDTC and ATC outcomes in patients who received radiation treatment. Radioisotope use and timing of radiotherapy (postoperative vs. preoperative) were associated with improved CSS in both histologies.

摘要

目的

低分化甲状腺癌(PDTC)和未分化甲状腺癌(ATC)被认为是头颈部最具侵袭性的癌症。本研究的目的是评估和比较基于大人群队列的PDTC和ATC患者的生存结局。

材料与方法

从监测、流行病学和最终结果数据库中获取1973年至2008年诊断为PDTC和ATC的患者。进行Kaplan-Meier生存分析和对数秩分析以评估:(1)组织学对特定病因生存率(CSS)的影响;(2)治疗、治疗顺序、种族、性别和年龄等因素对CSS的影响。进行多变量分析以评估这些因素对CSS的独立影响。

结果

共识别出1352例PDTC和ATC患者。PDTC患者占52.4%,ATC患者占47.6%。两个组织学组的中位CSS相似(P = 0.14)。与外照射相比,接受放射性同位素治疗的PDTC和ATC患者的CSS均显著更好(P < 0.0001)。与术后接受放疗的患者相比,术前接受放疗的PDTC和ATC患者的CSS显著更低(P < 0.0001)。女性性别和黑人/非白人种族倾向于改善PDTC和ATC患者的CSS(性别和种族的P值分别为0.29和0.03)。然而,多变量分析显示只有放疗类型和年龄与CSS独立相关。

结论

这是第一项基于大人群的研究,评估接受放疗的患者的PDTC和ATC结局。放射性同位素的使用和放疗时机(术后与术前)与两种组织学类型患者CSS的改善相关。

相似文献

1
Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.比较接受放疗的低分化与间变性甲状腺癌的治疗结果:一项监测、流行病学和最终结果分析。
J Cancer Res Ther. 2014 Jul-Sep;10(3):526-30. doi: 10.4103/0973-1482.138207.
2
Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.间变性和低分化甲状腺癌的临床病理特征变化及生存结局。
Thyroid. 2016 Mar;26(3):404-13. doi: 10.1089/thy.2015.0316. Epub 2015 Dec 14.
3
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database.基于 SEER 数据库构建并验证预测重新定义的间变性甲状腺癌患者总生存的列线图。
Int J Clin Oncol. 2024 Jun;29(6):744-754. doi: 10.1007/s10147-024-02495-2. Epub 2024 Apr 7.
4
Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.可切除的未分化或低分化甲状腺癌全切除术后的复发与生存情况
Thyroid. 2016 Sep;26(9):1259-68. doi: 10.1089/thy.2016.0147. Epub 2016 Aug 11.
5
Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.未分化甲状腺癌与间变性甲状腺癌的对比研究:真实世界的病理分布、死因归因和预后因素评估。
Front Endocrinol (Lausanne). 2024 Mar 13;15:1347362. doi: 10.3389/fendo.2024.1347362. eCollection 2024.
6
Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.间变性和低分化甲状腺癌:52 例连续患者的治疗策略和治疗结果。
Oncology. 2010;79(5-6):400-8. doi: 10.1159/000322640. Epub 2011 Mar 31.
7
Surgery combined with adjuvant radiation and chemotherapy prolonged overall survival in stage IVC anaplastic thyroid cancer: a SEER-based analysis.手术联合辅助放化疗延长 IVC 期间变性甲状腺癌的总生存期:基于 SEER 的分析。
Endocrine. 2024 Jul;85(1):250-257. doi: 10.1007/s12020-023-03662-7. Epub 2024 Jan 6.
8
Risk stratification in patients with anaplastic thyroid carcinoma: role of age.间变性甲状腺癌患者的风险分层:年龄的作用。
Endocrine. 2022 Aug;77(2):305-318. doi: 10.1007/s12020-022-03085-w. Epub 2022 May 24.
9
County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.县家庭收入中位数是IV期间变性甲状腺癌的独立预后因素。
Anticancer Res. 2019 Feb;39(2):949-956. doi: 10.21873/anticanres.13198.
10
Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.间变性甲状腺癌的预后因素和治疗结果:日本 ATC 研究联盟 677 例患者的队列研究。
World J Surg. 2012 Jun;36(6):1247-54. doi: 10.1007/s00268-012-1437-z.

引用本文的文献

1
Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.血液学参数及低分化甲状腺癌和间变性甲状腺癌临床病理特征的预测价值。
Langenbecks Arch Surg. 2024 Aug 6;409(1):241. doi: 10.1007/s00423-024-03431-8.
2
Differences Between Cancer-Specific Survival of Patients With Anaplastic and Primary Squamous Cell Thyroid Carcinoma and Factors Influencing Prognosis: A SEER Database Analysis.间变性和原发性甲状腺鳞状细胞癌患者的癌症特异性生存率差异及预后影响因素:一项监测、流行病学和最终结果(SEER)数据库分析
Front Endocrinol (Lausanne). 2022 Mar 10;13:830760. doi: 10.3389/fendo.2022.830760. eCollection 2022.
3
Anaplastic Thyroid Carcinoma: An Update.
间变性甲状腺癌:最新进展
Cancers (Basel). 2022 Feb 19;14(4):1061. doi: 10.3390/cancers14041061.
4
Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer.GSK-J4与阿霉素在KRAS突变型间变性甲状腺癌中的协同作用
Front Pharmacol. 2020 May 13;11:632. doi: 10.3389/fphar.2020.00632. eCollection 2020.
5
The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.间变性甲状腺癌的发病率及生存分析:一项监测、流行病学和最终结果(SEER)数据库分析
Am J Transl Res. 2019 Sep 15;11(9):5888-5896. eCollection 2019.
6
[Not Available].[无可用内容]。
Chirurg. 2016 Mar;87(3):247-50. doi: 10.1007/s00104-015-0061-5.